PATENT CLAIM ANALYSIS

Application Number: 16024183
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["435", "007100"]

Abstract:
The present invention provides methods for aiding in the diagnosis of irritable bowel syndrome (IBS) in an individual. In particular, the present invention is useful for determining whether the individual does not have either celiac disease or inflammatory bowel disease (IBD), and has IBS and/or a subtype thereof. Thus, the present invention provides an accurate diagnostic prediction of IBS and is useful for guiding treatment decisions.

Claim (Index 12):
The method of  claim 1 , wherein the method further comprises measuring an additional member selected from the group consisting of a mast cell score, an inflammatory score, a bile acid malabsorption score, an oxidative stress score, and a serotonin score.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.55102
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15646838', '14938729', '14673660', '14938710', '11841660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7104564498801709
- 35 USC 102 Novelty (BERT): 0.6668220422577936
- Combined Prediction Score: 0.7060930091179332
- Mean Citation Score: 528.663358
- Max Citation Score: 779.1139
- Similarity Product: 616.4082014713406

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test